Search

Showing total 124 results

Search Constraints

Start Over You searched for: Topic vaccines Remove constraint Topic: vaccines Language english Remove constraint Language: english Journal frontiers in immunology Remove constraint Journal: frontiers in immunology
124 results

Search Results

1. Coadministration of Anti-Viral Monoclonal Antibodies With Routine Pediatric Vaccines and Implications for Nirsevimab Use: A White Paper.

2. Quantum vaccinomics platforms to advance in vaccinology.

3. CCHFV vaccine development, current challenges, limitations, and future directions.

4. A novel vaccine formulation candidate based on lipooligosaccharides and pertussis toxin against Bordetella pertussis.

5. SEMA: Antigen B-cell conformational epitope prediction using deep transfer learning.

6. Modulation of dendritic cell metabolism by an MPLA-adjuvanted allergen product for specific immunotherapy.

7. Potential of Polyethyleneimine as an Adjuvant To Prepare Long-Term and Potent Antifungal Nanovaccine.

8. Mapping the Mechanical and Immunological Profiles of Polymeric Microneedles to Enable Vaccine and Immunotherapy Applications.

9. Editorial: Immunoparasitology: A Unique Interplay Between Host and Pathogen.

10. The Role of Systems Vaccinology in Understanding the Immune Defects to Vaccination in Solid Organ Transplant Recipients.

11. Fake News or Weak Science? Visibility and Characterization of Antivaccine Webpages Returned by Google in Different Languages and Countries.

12. Editorial: Conference research topic: 16th international symposium on schistosomiasis NEW ('th') presented in superscript.

13. Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development.

14. Computational Pipeline for the PGV-001 Neoantigen Vaccine Trial.

15. Development of a live attenuated vaccine candidate for equid alphaherpesvirus 1 control: a step towards efficient protection.

16. A highly effective ferritin-based divalent nanoparticle vaccine shields Syrian hamsters against lethal Nipah virus.

17. Heterologous Ad26/Ad5 adenovirus-vectored vaccines elicited SARS-CoV-2-specific antibody responses with potent Fc activities.

18. Editorial: Women in cancer immunity and immunotherapy.

19. Plasmodium vivax cell-Traversal Protein for Ookinetes and Sporozoites: Naturally Acquired Humoral Immune Response and B-Cell Epitope Mapping in Brazilian Amazon Inhabitants.

20. Current status of immunological therapies for rheumatoid arthritis with a focus on antigen-specific therapeutic vaccines.

21. The major epidemiologic, microbiologic, immunologic, and clinical aspects of Lyme disease that form the basis for a newly developed vaccine that may become available soon for human use.

22. Development and application of the direct mycobacterial growth inhibition assay: a systematic review.

23. Vaccine development against tuberculosis before and after Covid-19.

24. Bacterial outer membrane vesicles and vaccine applications.

26. Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trial.

27. CCHFV vaccine development, current challenges, limitations, and future directions

28. Metabolomics acts as a powerful tool for comprehensively evaluating vaccines approved under emergency: a CoronaVac retrospective study.

29. Maternal vaccination: shaping the neonatal response to pertussis.

30. How to train your myeloid cells: a way forward for helminth vaccines?

31. Assessment of human milk samples obtained pre and post-influenza vaccination reveals a poor boosting of seasonally-relevant, hemagglutinin-specific antibodies.

32. Understanding preclinical and clinical immunogenicity risks in novel biotherapeutics development.

33. Glycan masking in vaccine design: Targets, immunogens and applications.

34. Pre-clinical models to define correlates of protection for SARS-CoV-2.

36. Mathematical modelling of the waning of anti-RBD IgG SARS-CoV-2 antibody titers after a two-dose BNT162b2 mRNA vaccination.

37. Design and immunological evaluation of two-component protein nanoparticle vaccines for East Coast fever.

38. Research progress on circular RNA vaccines.

39. Integrativesubtractive proteomics, immunoinformatics, docking, and simulation approaches reveal candidate vaccine against Sin Nombre orthohantavirus.

40. Moving the needle: Employing deep reinforcement learning to push the boundaries of coarsegrained vaccine models.

41. Fully understanding the efficacy profile of the COVID-19 vaccination and its associated factors in multiple real-world settings.

42. Characteristics of clinical trials for non-small cell lung cancer therapeutic vaccines registered on ClinicalTrials.gov.

43. Vaccine models predict rules for updating vaccines against evolving pathogens such as SARS-CoV-2 and influenza in the context of pre-existing immunity.

44. Immunogenicity and safety of two-dose SARS-CoV-2 vaccination via different platforms in kidney transplantation recipients.

45. Inactivated vaccine Covaxin/BBV152: A systematic review.

46. Editorial: Mucosal vaccines for the induction of antimicrobial immunoglobulin A.

47. Immunoinformatics Approach Toward the Introduction of a Novel Multi-Epitope Vaccine Against Clostridium difficile.

48. At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant.

49. Advances in Human Dendritic Cell-Based Immunotherapy Against Gastrointestinal Cancer.

50. The Road to Elimination: Current State of Schistosomiasis Research and Progress Towards the End Game.